GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Cyclically Adjusted PS Ratio

Easywell Biomedicals (ROCO:1799) Cyclically Adjusted PS Ratio : 17.10 (As of May. 26, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Easywell Biomedicals's current share price is NT$105.00. Easywell Biomedicals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$6.14. Easywell Biomedicals's Cyclically Adjusted PS Ratio for today is 17.10.

The historical rank and industry rank for Easywell Biomedicals's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:1799' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.58   Med: 3.49   Max: 17.1
Current: 17.1

During the past years, Easywell Biomedicals's highest Cyclically Adjusted PS Ratio was 17.10. The lowest was 1.58. And the median was 3.49.

ROCO:1799's Cyclically Adjusted PS Ratio is ranked worse than
93.45% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.26 vs ROCO:1799: 17.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Easywell Biomedicals's adjusted revenue per share data for the three months ended in Mar. 2024 was NT$0.626. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$6.14 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Easywell Biomedicals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Easywell Biomedicals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Cyclically Adjusted PS Ratio Chart

Easywell Biomedicals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 3.94 3.55 2.56 6.74

Easywell Biomedicals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 3.58 3.45 6.74 11.32

Competitive Comparison of Easywell Biomedicals's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Easywell Biomedicals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easywell Biomedicals's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Easywell Biomedicals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Easywell Biomedicals's Cyclically Adjusted PS Ratio falls into.



Easywell Biomedicals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Easywell Biomedicals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=105.00/6.14
=17.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easywell Biomedicals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Easywell Biomedicals's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.626/131.7762*131.7762
=0.626

Current CPI (Mar. 2024) = 131.7762.

Easywell Biomedicals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.558 100.560 0.731
201409 1.081 100.428 1.418
201412 4.045 99.070 5.380
201503 3.304 99.621 4.370
201506 3.574 100.684 4.678
201509 1.767 100.392 2.319
201512 1.955 99.792 2.582
201603 0.499 100.470 0.654
201606 1.507 101.688 1.953
201609 2.837 101.861 3.670
201612 1.875 101.863 2.426
201703 1.713 102.862 2.195
201706 1.827 103.349 2.330
201709 1.653 104.136 2.092
201712 1.041 104.011 1.319
201803 1.318 105.290 1.650
201806 1.192 106.317 1.477
201809 1.367 106.507 1.691
201812 2.124 105.998 2.641
201903 1.136 107.251 1.396
201906 1.397 108.070 1.703
201909 1.032 108.329 1.255
201912 0.993 108.420 1.207
202003 0.874 108.902 1.058
202006 0.741 108.767 0.898
202009 0.357 109.815 0.428
202012 0.881 109.897 1.056
202103 0.726 111.754 0.856
202106 0.460 114.631 0.529
202109 0.363 115.734 0.413
202112 0.321 117.630 0.360
202203 0.303 121.301 0.329
202206 0.305 125.017 0.321
202209 0.371 125.227 0.390
202212 0.578 125.222 0.608
202303 0.320 127.348 0.331
202306 0.612 128.729 0.626
202309 0.597 129.860 0.606
202312 0.828 129.419 0.843
202403 0.626 131.776 0.626

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Easywell Biomedicals  (ROCO:1799) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Easywell Biomedicals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Easywell Biomedicals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Easywell Biomedicals (ROCO:1799) Business Description

Traded in Other Exchanges
N/A
Address
No.10, Yanfa 2nd Rd, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076
Easywell Biomedicals Inc is engaged in the design, manufacture, and sales of thermometers for measuring body temperature and other medical instruments such as digital clinical thermometers, infrared ear thermometers, probe covers, and blood/urine/total cholesterol metabolites monitoring systems, among others. It has a Drug development segment and Other segments.

Easywell Biomedicals (ROCO:1799) Headlines

No Headlines